ICF International, Inc.
ICFI News Today: Stay Updated with the Latest ICF International, Inc. News in Real Time
Find ICFI news now at Meyka AI. Stay informed with the latest ICF International, Inc. stocks updates, including price news, market analysis, and expert insights.

Canada Parental Abduction: 5-Year Sentence, Repatriation Orders — April 9
Parental child abduction canad case: Quebec issues five-year prison term and strict probation to repatriate two children from Algeria, highlighting international custody enforcement and deportation 风险

Pre-market: AIDX.TO Healwell AI C$0.82 on 09 Apr 2026: earnings catalyst ahead
AIDX.TO stock pre-market at C$0.82 on 09 Apr 2026 with May earnings and model forecasts signaling downside and volatility

Volume spike: TLFX Telefix (PNK) $0.00030 on 09 Apr 2026, check liquidity
TLFX stock volume spike to $0.00030 on 09 Apr 2026; short-term liquidity and outlook for TLFX stock

France vs Norway Full Scorecard: Complete Batting and Bowling Stats from ICC Match 9
The France vs Norway clash in Match 9 of the Portugal T20I Tri-Series delivered an exciting contest filled with strong batting performances and decisive bowling spells. Played at Santarem Cricket Ground, the match saw Norway secure a narrow victory after defending a competitive total. Fans witnessed a balanced game where momentum shifted several times before…

PRST stock pre-market: Presto Automation (NASDAQ) down 99.87%, watch liquidity
Pre-market top loser: PRST stock plunges 99.87% on NASDAQ; analysis of market cap, volume, and forecast

BTIG Upgrades LNSR (LENSAR, Inc.) to Buy March 2026
BTIG upgrades LNSR to Buy on March 17, 2026; our LNSR analyst rating summary and implications

BTIG Maintains Buy on Aldeyra Therapeutics (ALDX) March 2026
BTIG maintained Buy on Aldeyra; ALDX analyst rating points to regulatory clarity in 90 days

WEC Insider Trading: Three Directors Acquire Phantom Stock Units
WEC Energy Group directors acquire 924 phantom stock units on April 7, 2026. Cunningham, Stanek, and Lane file Form 4 SEC filings showing insider buying activity.

SMMT Analyst Rating: Citigroup Initiates Buy Coverage April 2026
Citigroup initiates Buy coverage on Summit Therapeutics (SMMT) with initial rating, citing scarcity value in competitive drug market.